Retagletide presents a novel approach to managing type 2 diabetes. This effective GLP-1 receptor activator exhibits promising results in clinical trials, underscoring its potential capability in enhancing glycemic https://mediajx.com/story26393114/retagletide-a-novel-glp-1-receptor-agonist-for-type-2-diabetes